R

Revelation Biosciences, Inc. Common StockREVB

Revelation Biosciences, Inc. is a clinical stage life sciences company focused on rebalancing inflammation using its proprietary formulation Gemini. Revelation has multiple ongoing programs to evaluate Gemini, including the treatment of chronic kidney disease, prevention for post-surgical infection and as a treatment for acute kidney.

US StocksHealthcareSmall CapBiotechnology

REVB の価格トレンド

Revelation Biosciences, Inc. Common Stock · TradingView フルチャート

NASDAQ:REVB

オンチェーンアクティビティ